COSMOS Pharmaceutical Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
May'24
May'23
May'22
May'21
May'20
May'19
No of Months
12
12
12
12
12
12
Profit Before Tax
33,719.00
32,773.00
33,048.00
38,596.00
30,402.00
27,139.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
9,666.00
13,205.00
-2,432.00
-12,560.00
29,098.00
1,387.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
55,175.00
54,434.00
32,194.00
27,875.00
65,461.00
34,379.00
Cash Flow from Investing Activities
-57,329.00
-49,113.00
-43,717.00
-19,381.00
-26,956.00
-30,042.00
Cash Flow from Financing Activities
8,527.00
3,245.00
-6,222.00
-5,507.00
-5,405.00
-6,982.00
Net Cash Inflow / Outflow
6,373.00
8,566.00
-17,745.00
2,987.00
33,100.00
-2,645.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of COSMOS Pharmaceutical Corp.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
33719
26277
7,442.00
28.32%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
9666
-5957
15,623.00
262.26%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
55175
47845
7,330.00
15.32%
Cash Flow from Investing Activities
-57329
-22736
-34,593.00
-152.15%
Cash Flow from Financing Activities
8527
-20774
29,301.00
141.05%
Net Cash Inflow / Outflow
6373
4340
2,033.00
46.84%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
5
-5.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - May'24
YoY Growth in year ended May 2024 is 1.36% vs 69.08% in May 2023
May'24
May'23
Change(%)
Cash Flow from Operating Activities
55,175.00
54,434.00
1.36%






